Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single‐institution study with propensity score‐matched comparative analysis.

MLA

Sun, Xi‐yu, et al. “Neoadjuvant Chemoradiotherapy Might Provide Survival Benefit in Patients with Stage IIIb/IIIc Locally Advanced Rectal Cancer: A Retrospective Single‐institution Study with Propensity Score‐matched Comparative Analysis.” Asia Pacific Journal of Clinical Oncology, vol. 16, no. 3, June 2020, pp. 142–49. EBSCOhost, https://doi.org/10.1111/ajco.13306.

APA

Sun, X., Cai, S., Xu, L., Luo, D., Qiu, H., Wu, B., Lin, G., Lu, J., Zhang, G., & Xiao, Y. (2020). Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single‐institution study with propensity score‐matched comparative analysis. Asia Pacific Journal of Clinical Oncology, 16(3), 142–149. https://doi.org/10.1111/ajco.13306

Chicago

Sun, Xi‐yu, Song‐hua Cai, Lai Xu, Dan Luo, Hui‐zhong Qiu, Bin Wu, Guo‐le Lin, Jun‐yang Lu, Guan‐nan Zhang, and Yi Xiao. 2020. “Neoadjuvant Chemoradiotherapy Might Provide Survival Benefit in Patients with Stage IIIb/IIIc Locally Advanced Rectal Cancer: A Retrospective Single‐institution Study with Propensity Score‐matched Comparative Analysis.” Asia Pacific Journal of Clinical Oncology 16 (3): 142–49. doi:10.1111/ajco.13306.